In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
PBMs run prescription drug coverage for insurers ... insulin has emerged as a big campaign topic during this year’s ...
In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
And when getting a prescription filled requires waiting hours — or even days. “Pharmacists used to be busy if they filled 200 ...
Rand told lawmakers that for about the past year, health insurance plans and pharmacy benefit managers have been reimbursing ...
A recent report from U.S. Pharmacist reveals that almost 46% of Americans are prescribed at least one medication each month.
Chains and independent pharmacies alike are short-staffed, leading to long lines and frustrating experiences. Here's why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback